It seems really doubtful a startup would have two breakthrough drugs in different categories. I wouldn't answer an email with this information either. Plus the light conspiracy talk about pharma companies wanting a treatment not a cure... It reduces your legitimacy. Look at the hepatitis cure, it's one of the biggest blockbusters of recent history.

How have you funded the R&D necessary to discover these compounds?